101 research outputs found

    Serum based screening and molecular detection of brucellosis in ruminants

    Get PDF
    22-25Brucellosis is a highly infectious bacterial disease that mainly affects cattle, sheep, pigs, goats, dogs, horses and wild animals primarily caused by Brucella abortus, B. ovis, B. suis, B. melitensis, and B. canis. It has a significant threat to the livestock and human community mainly in developing countries and requires accurate diagnosis, characterization and management. This study was undertaken in 238 samples (112 serum samples from the sheep, 82 serum samples from the goat and 44 serum samples from the cattle) suspected of brucellosis collected from the southern districts of Tamil Nadu. All the 238 samples were screened for the brucellosis by carrying out rose bengal plate agglutination test (RBPT). The seropositive serum samples were further subjected to Brucella cell surface salt extractable protein 31 (BCSP 31) gene-based PCR for Brucella genus confirmation. The BCSP 31-PCR positive samples were further subjected to Brucella-AMOS (avis-melitensis-ovis-suis) multiplex PCR for identification of B. abortus, B. ovis, B. melitensis and B. suis species. The study revealed that 8.92% (n = 10) serum samples from sheep, 9.75% (n = 8) serum samples from goat and 6.81% (n = 3) serum samples from cattle were seropositive for brucellosis by RBPT. All the twenty one seropositive samples produced specific amplicon of 223 bp by BCSP 31-PCR confirms brucellosis. Further molecular typing of BCSP 31-PCR positive samples by Brucella –AMOS  PCR revealed specific amplicon of 498 bp indicating the involvement of B. abortus in 19 serum (10 from sheep, 6 from goat and 3 from cattle) samples. One serum sample from goat revealed specific amplicons of 498 bp and 731 bp indicating the involvement of both B. abortus and B. meletensis. Another serum sample from goat yielded specific amplicons of 498 bp, 731 bp and 285 bp suggesting the mixed infection of B. abortus, B. meletensis and B. suis, respectively. The B. abortus is the common species involved in cattle, sheep and goat infections. Two caprine samples showed mixed infection which involves B. abortus, B. meletensis and B. suis species. The study concludes that the serum can be used as an alternate specimen for the fast and reliable molecular diagnosis of brucellosis

    Desenvolvimento, avaliação e lançamento da cultivar precoce Guarani para o arroz de sequeiro

    Get PDF
    The process of selection of the line CNAx 095-BM 30-BM 9-28 was described and the results of the evaluations presented. The line originated from the cross 63-83/IAC 25 after two cycles of modified bulk (F2 and F3) followed by one cycle of pedigree selection (F4). Grain yield, leaf and neck blast were evaluated in preliminary and advanced yield trials conducted in four Brazilian states. The line overall grain yield mean was 19.4% higher than that of the check (IAC 165). For the states of Mato Grosso, Goiás, Minas Gerais and Mato Grosso do Sul the grain yield increase over the check was 17.7%, 22.7%, 26.6% and 7.3%, respectively. The line showed higher leaf and neck blast resistance. The line was agronomically described and commercialy released with the name of Guarani. Descreve-se o processo de seleção e apresentados os resultados das avaliações da linhagem de ciclo curto CNAx 095-BM 30-BM 9-28. A linhagem foi selecionada do cruzamento 63-83/IAC 25, através de duas gerações de seleção populacional modificada (F2 e F3), seguida de uma geração de seleção genealógica (F4). As avaliações de rendimento, de incidência de brusone nas folhas e no pescoço foram conduzidas em ensaio comparativo preliminar e avançado, em quatro estados brasileiros. A média geral da produção de grãos da linhagem foi 19,4% superior à da testemunha IAC 165, sendo 17,7%; 22,7%; 26,6% e 7,3% para os estados de Mato Grosso, Goiás, Minas Gerais e Mato Grosso do Sul, respectivamente. A resposta da linhagem à brusone nas folhas e no pescoço também foi superior. A linhagem foi caracterizada agronomicamente e lançada comercialmente com o nome de Guarani.

    Towards the introduction of the ‘Immunoscore’ in the classification of malignant tumours

    Get PDF
    The American Joint Committee on Cancer/Union Internationale Contre le Cancer (AJCC/UICC) TNM staging system provides the most reliable guidelines for the routine prognostication and treatment of colorectal carcinoma. This traditional tumour staging summarizes data on tumour burden (T), the presence of cancer cells in draining and regional lymph nodes (N) and evidence for distant metastases (M). However, it is now recognized that the clinical outcome can vary significantly among patients within the same stage. The current classification provides limited prognostic information and does not predict response to therapy. Multiple ways to classify cancer and to distinguish different subtypes of colorectal cancer have been proposed, including morphology, cell origin, molecular pathways, mutation status and gene expression-based stratification. These parameters rely on tumour-cell characteristics. Extensive literature has investigated the host immune response against cancer and demonstrated the prognostic impact of the in situ immune cell infiltrate in tumours. A methodology named ‘Immunoscore’ has been defined to quantify the in situ immune infiltrate. In colorectal cancer, the Immunoscore may add to the significance of the current AJCC/UICC TNM classification, since it has been demonstrated to be a prognostic factor superior to the AJCC/UICC TNM classification. An international consortium has been initiated to validate and promote the Immunoscore in routine clinical settings. The results of this international consortium may result in the implementation of the Immunoscore as a new component for the classification of cancer, designated TNM-I (TNM-Immune). © 2013 The Authors. Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland

    Clinical history and management recommendations of the smooth muscle dysfunction syndrome due to ACTA2 arginine 179 alterations

    Get PDF
    Smooth muscle dysfunction syndrome (SMDS) due to heterozygous ACTA2 arginine 179 alterations is characterized by patent ductus arteriosus, vasculopathy (aneurysm and occlusive lesions), pulmonary arterial hypertension, and other complications in smooth muscle-dependent organs. We sought to define the clinical history of SMDS to develop recommendations for evaluation and management. Medical records of 33 patients with SMDS (median age 12 years) were abstracted and analyzed. All patients had congenital mydriasis and related pupillary abnormalities at birth and presented in infancy with a patent ductus arteriosus or aortopulmonary window. Patients had cerebrovascular disease characterized by small vessel disease (hyperintense periventricular white matter lesions; 95%), intracranial artery stenosis (77%), ischemic strokes (27%), and seizures (18%). Twelve (36%) patients had thoracic aortic aneurysm repair or dissection at median age of 14 years and aortic disease was fully penetrant by the age of 25 years. Three (9%) patients had axillary artery aneurysms complicated by thromboembolic episodes. Nine patients died between the ages of 0.5 and 32 years due to aortic, pulmonary, or stroke complications, or unknown causes. Based on these data, recommendations are provided for the surveillance and management of SMDS to help prevent early-onset life-threatening complications
    corecore